The present study was designed to evaluate neurotensin as a hormonal regulator of gastric acid secretion in man. After a fat-rich meal, the strongest known stimulus of neurotensin release, plasma neurotensin-like immunoreactivity (NTLI) was elevated from 7.6 +/- 1.9 to 15.5 +/- 2.5 pM. Plasma NTLI was measured with antiserum L170, which requires the biologically active carboxyl-terminal hexapeptide of the neurotensin molecule for recognition and does not crossreact significantly with any known natural catabolite in human plasma. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 resulted in a plasma level of 14.7 +/- 2.1 pM, similar to the maximal physiological level observed after the fat-rich meal. Intravenous infusion of neurotensin at 25 pmol X kg-1 h-1 during 2 h, however, failed to significantly inhibit peptone meal-stimulated gastric acid secretion measured by intragastric titration. The 2-h acid output to peptone was 40.8 +/- 6.2 and 41.3 +/- 6.9 mmol during the vehicle and the neurotensin infusion, respectively. Intravenous infusion of neurotensin at 100 or 400 pmol X kg-1 h-1 did not affect acid output, whereas at 1,600 pmol X kg-1 h-1, which resulted in a plasma neurotensin concentration of 725 +/- 80 pM, significantly reduced peptone meal-stimulated gastric acid secretion. The neurotensin-induced inhibition of acid output was independent of the hormone gastrin. The present results provide evidence against a hormonal role for neurotensin in the regulation of meal-stimulated gastric acid secretion in man.
M H Mogard, V Maxwell, B Sytnik, J H Walsh
Title and authors | Publication | Year |
---|---|---|
Plasma Proneurotensin and Prediction of Cause-Specific Mortality in a Middle-aged Cohort During Long-term Follow-up.
Fawad A, Bergmann A, Schulte J, Butt ZA, Nilsson PM, Bennet L, Orho-Melander M, Melander O |
The Journal of clinical endocrinology and metabolism | 2022 |
Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism
KV Grunddal, CF Ratner, B Svendsen, F Sommer, MS Engelstoft, AN Madsen, J Pedersen, MK Nøhr, KL Egerod, AR Nawrocki, T Kowalski, AD Howard, SS Poulsen, S Offermanns, F Bäckhed, JJ Holst, B Holst, TW Schwartz |
Endocrinology | 2016 |
Handbook of Biologically Active Peptides
DM Pollock |
Handbook of Biologically Active Peptides | 2013 |
Gastric Acid, Calcium Absorption, and Their Impact on Bone Health
S Kopic, JP Geibel |
Physiological reviews | 2013 |
Physiology of the Gastrointestinal Tract, Two Volume Set
PR Kiela, JF Collins, FK Ghishan |
Physiology of the Gastrointestinal Tract, Two Volume Set | 2012 |
Physiology of the Gastrointestinal Tract
DJ Drucker |
Physiology of the Gastrointestinal Tract | 2006 |
Gastrointestinal Physiology
WC Orr |
Principles and Practice of Sleep Medicine | 2005 |
Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in men
Maas, Hopman, Katan, Jansen |
European Journal of Clinical Investigation | 1998 |
Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man
A Wettergren, P Maina, S Boesby, JJ Holst |
Scandinavian Journal of Gastroenterology | 1997 |
Inhibition of gastrin-stimulated gastric acid secretion by medium-chain triglycerides and long-chain triglycerides in healthy young men
MI Maas, WP Hopman, MB Katan, JB Jansen |
Regulatory Peptides | 1996 |
Ileal release of glucagon-like peptide-1 (GLP-1)
P Layer, JJ Holst, D Grandt, H Goebell |
Digestive Diseases and Sciences | 1995 |
Ileal release of glucagon-like peptide-1 (GLP-1): Association with inhibition of gastric acid secretion in humans
P Layer, JJ Holst, D Grandt, H Goebell |
Digestive Diseases and Sciences | 1995 |
5 Gut hormones in gastric function
KC Lloyd |
Baillière's Clinical Endocrinology and Metabolism | 1994 |
Gastrointestinal Regulatory Peptides
DR Brown |
1993 | |
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
A Wettergren, B Schjoldager, PE Mortensen, J Myhre, J Christiansen, JJ Holst |
Digestive Diseases and Sciences | 1993 |
Gut hormones and diabetes mellitus
W Creutzfeldt, M Nauck |
Diabetes / Metabolism Reviews | 1992 |
Mechanisms of Neurotensin Effects on Pancreatic and Duodenal Bicarbonate Secretion in the Rat
C Nagain, D Merlin, J Chariot, C Rozé |
Annals of the New York Academy of Sciences | 1992 |
Induction of the fed pattern of human exocrine pancreatic secretion by nutrients: role of cholecystokinin and neurotensin
M Katschinski, C Dippel, M Reinshagen, J Schirra, R Arnold, R Nustede, C Beglinger, G Adler |
The Clinical Investigator | 1992 |
Plasma levels of human neurotensin: Methodological and physiological considerations
CF Ferris, JK George, G Eastwood, M Potegal, RE Carraway |
Peptides | 1991 |
Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin
RA Hammer, C Fernandez, A Ertan, A Arimura |
Life Sciences | 1991 |
Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog
T Hashimoto, F Lluis, G Gomez, FL Hill, GH Greeley, JC Thompson |
Digestive Diseases and Sciences | 1991 |
Action of Neurotensin on Meal-Stimulated Gastric Acid Secretion in the Dog
VE Eysselein, WH Hesse, GA Eberlein, C Koelbel, W Niebel, H Goebell |
Scandinavian Journal of Gastroenterology | 1990 |
Inhibitory effect of neurotensin on gastric acid secretion in rats: Development of a bioassay model
RA Hammer, RE Hernandez, A Shepard |
Digestive Diseases and Sciences | 1990 |